{"id":286166,"date":"2024-08-27T00:00:00","date_gmt":"2024-08-27T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidcv0043-biopharma-chronic-pain-current-treatment-epidemiology-dashboard\/"},"modified":"2026-03-31T10:28:44","modified_gmt":"2026-03-31T10:28:44","slug":"epidcv0043-biopharma-chronic-heart-failure-epidemiology-epidemiology-dashboard","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidcv0043-biopharma-chronic-heart-failure-epidemiology-epidemiology-dashboard\/","title":{"rendered":"Chronic Heart Failure &#8211; Epidemiology &#8211; Epidemiology Dashboard"},"content":{"rendered":"<p>Clarivate Epidemiology\u2019s coverage of heart failure (<abbr title=\"heart failure\">HF<\/abbr>) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed event rates of <abbr title=\"acute heart failure\">AHF<\/abbr> and the diagnosed prevalence of <abbr title=\"chronic heart failure\">CHF<\/abbr> for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Most patient populations are forecast over a period of 20 years for the mature markets and Europe and 10 years for the other countries we cover.<\/p>\n<p>All forecast data are available on Clarivate\u2019s Insights Platform in tabular format, with options to download to <span class=\"abbreviation-guard\">MS<\/span> Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>Clarivate Epidemiology\u2019s <abbr title=\"heart failure\">HF<\/abbr> forecast answers the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>In developing countries, what impact will economic growth and development have on the number of people diagnosed with severe disease?<\/li>\n<li>Of all <abbr title=\"acute heart failure\">AHF<\/abbr> hospitalization events, how many in each of the major mature pharmaceutical markets are drug-treated?<\/li>\n<li>Of all people diagnosed with <abbr title=\"chronic heart failure\">CHF<\/abbr>, how many in each of the major mature pharmaceutical markets are drug-treated?<\/li>\n<li>How will demographic trends such as population aging and improving life expectancy affect the epidemiology of <abbr title=\"heart failure\">HF<\/abbr> over the forecast period?<\/li>\n<\/ul>\n<p>In addition to the total number of cases for each forecast year, Clarivate Epidemiology provides at least 10 years of forecast data for the following <abbr title=\"heart failure\">HF<\/abbr> subpopulations:<\/p>\n<ul class=\"round-bullets\">\n<li>Diagnosed <abbr title=\"acute heart failure\">AHF<\/abbr> events by ejection fraction.<\/li>\n<li>Diagnosed <abbr title=\"acute heart failure\">AHF<\/abbr> events by treatment status.<\/li>\n<li>Diagnosed <abbr title=\"acute heart failure\">AHF<\/abbr> events by subpopulation.<\/li>\n<li>Diagnosed <abbr title=\"chronic heart failure\">CHF<\/abbr> prevalent cases by severity.<\/li>\n<li>Diagnosed <abbr title=\"chronic heart failure\">CHF<\/abbr> prevalent cases by treatment scheme.<\/li>\n<li>Diagnosed <abbr title=\"chronic heart failure\">CHF<\/abbr> prevalent cases by ejection fraction.<\/li>\n<li>Diagnosed <abbr title=\"chronic heart failure\">CHF<\/abbr> prevalent cases by comorbidity.<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country.<\/p>\n","protected":false},"template":"","class_list":["post-286166","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-cardiovascular","biopharma-therapy-areas-chronic-heart-failure","biopharma-therapy-areas-chronic-pain","biopharma-therapy-areas-heart-failure","biopharma-product-current-treatment","biopharma-product-epidemiology","biopharma-date-985"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/286166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":3,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/286166\/revisions"}],"predecessor-version":[{"id":374603,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/286166\/revisions\/374603"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=286166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}